Imipramine-induced hyperpigmentation of the skin
Mehr, N.; Wu, J.J.; Dyson, S.W.; Woseth, D.M.
Dermatology Online Journal 13(4): 8
2007
ISSN/ISBN: 1087-2108 PMID: 18319005 Document Number: 605970
Document emailed within 1 workday
Related Documents
E Silva, L.ís.P.C.T.; Luís, F.; Cabrera, H. 2008: Facial hyperpigmentation. amiodarone-induced hyperpigmentation American Family Physician 78(11): 1297-1298Makino, E.T.T.; Mehta, R.C.C.; Banga, A.; Jain, P.; Sigler, M.L.L.; Sonti, S. 2013: Evaluation of a hydroquinone-free skin brightening product using in vitro inhibition of melanogenesis and clinical reduction of ultraviolet-induced hyperpigmentation Journal of Drugs in Dermatology: Jdd 12(3): S16-S20
Kalamkarian, A.A.; ShadyevHK 1984: Paraneoplastic hyperpigmentation of the skin Vestnik Dermatologii i Venerologii 6: 4-7
Fabi, S.; Massaki, N.; Goldman, M.P. 2012: Efficacy and tolerability of two commercial hyperpigmentation kits in the treatment of facial hyperpigmentation and photo-aging Journal of Drugs in Dermatology: Jdd 11(8): 964-968
Woolery-Lloyd, H.C.; Keri, J.; Doig, S. 2013: Retinoids and azelaic acid to treat acne and hyperpigmentation in skin of color Journal of Drugs in Dermatology: Jdd 12(4): 434-437
Tan, K.L.; Kurniawati, C.; Gold, M.H. 2008: Low risk of postinflammatory hyperpigmentation in skin types 4 and 5 after treatment with fractional CO2 laser device Journal of Drugs in Dermatology: Jdd 7(8): 774-777
Yukishige, K.; Fujimoto, S.; Ueyama, H.; Fujiwara, S.; Kumamoto, T.; Tsuda, T. 1999: Two adult siblings with Chédiak-Higashi syndrome presenting as hyperpigmentation of the skin and the iris Rinsho Shinkeigaku 39(7): 735-738
Kumar, L.; Kochipillai, V. 1990: Mitoxantrone induced hyperpigmentation New Zealand Medical Journal 103(883): 55
Samos-Zielińska, J.; Lańcucki, J.; Dabrowski, J.; Sadowska-Iwańciow, H. 1979: Chronic toxic erythemo-macular skin hyperpigmentation (erythema dyschromicum perstans, ashy dermatosis Przeglad Dermatologiczny 66(4): 385-391
Roberts, W.E. 2015: Pollution as a risk factor for the development of melasma and other skin disorders of facial hyperpigmentation ‑ is there a case to be made? Journal of Drugs in Dermatology: Jdd 14(4): 337-341
Granstein, R.D.; Sober, A.J. 1981: Drug- and heavy metal--induced hyperpigmentation Journal of the American Academy of Dermatology 5(1): 1-18
Bhatia, A.; Hsu, J.T.; Hantash, B.M. 2014: Combined topical delivery and dermalinfusion of decapeptide-12 accelerates resolution of post-inflammatory hyperpigmentation in skin of color Journal of Drugs in Dermatology: Jdd 13(1): 84-85
Al Mohizea, S. 2013: The effect of menstrual cycle on laser induced hyperpigmentation Journal of Drugs in Dermatology: Jdd 12(12): 1335-1336
Pui, J.C.; Meehan, S.; Moskovits, T. 2002: Capecitabine induced cutaneous hyperpigmentation: report of a case Journal of Drugs in Dermatology: Jdd 1(2): 202-205
Vanaman Wilson, M.J.; Jones, I.T.; Bolton, J.; Larsen, L.; Wu, D.C.; Goldman, M.P. 2017: A Randomized, Investigator-Blinded Comparison of two Topical Regimens in Fitzpatrick Skin Types III-Vi with Moderate to Severe Facial Hyperpigmentation Journal of Drugs in Dermatology: Jdd 16(11): 1127-1132
Fabi, S.G.; Goldman, M.P. 2013: Comparative study of hydroquinone-free and hydroquinone-based hyperpigmentation regimens in treating facial hyperpigmentation and photoaging Journal of Drugs in Dermatology: Jdd 12(3): S32-S37
Szymura-Oleksiak, J.; Panas, M.; Chruściel, W. 1984: The distribution of imipramine and desipramine in rat brain regions after single and chronic administration of imipramine Polish Journal of Pharmacology and Pharmacy 36(1): 21-26
Friedman, D.; Kutscher, T.D. 2016: Minimal energy eMatrix treatment combined with elure application for an expedited response in the treatment of hyperpigmentation and overall facial skin rejuvenation: A case report series Journal of Cosmetic and Laser Therapy 18(2): 66-68
Duncan, G.E.; Paul, I.A.; Powell, K.R.; Fassberg, J.B.; Stumpf, W.E.; Breese, G.R. 1989: Neuroanatomically selective down-regulation of beta adrenergic receptors by chronic imipramine treatment: relationships to the topography of [3H]imipramine and [3H] desipramine binding sites Journal of Pharmacology and Experimental Therapeutics 248(1): 470-477
Shelkunov, E.L. 1978: Effect of imipramine-like antidepressants on head shaking induced by 5-hydroxytryptophan in mice Biulleten' Eksperimental'noi Biologii i Meditsiny 86(9): 304-306